On 27 October 2021, SKAN Group AG, a global market leader in high-quality isolator systems for aseptic production processes in the (bio)pharmaceutical industry, announced the pricing of its IPO, consisting of 1,731,494 newly issued shares and 2,768,506 existing shares and an over-allotment option of up to 500,000 shares, at CHF 54 per share, implying a total market capitalization of CHF 1.214 billion. SKAN’s shares started trading on SIX Swiss Exchange on 28 October 2021.
CapLaw Themes
- FinSA (FIDLEG) (32)
- FinIA (FINIG) (11)
- Insurance (8)
- Securities (92)
- Regulatory (128)
- Takeover (19)
- Derivatives (7)
- News, Deals & Cases (450)
- Events (149)
- Other Areas (8)
CapLaw PDF Archive
Discover more articles
We provide up-to-date information on legal and regulatory developments regarding the capital markets, publish concise articles on developments in the Swiss and international financial markets, and announce recent deals and forthcoming events.